Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-25

Clinical Trial Update: A First in hUman Study for Resistant Epilepsy With the Vagus Nerve stimulatiOn Device by syneRgia medicAl [NA]

View source ↗

Summary

First-in-human study of a vagus nerve stimulation device by Synergia Medical for drug-resistant epilepsy; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vagus nerve stimulation device

Snippet

Sponsor: Synergia Medical | Conditions: Drug Resistant Epilepsy | NA | Status: ACTIVE_NOT_RECRUITING